537 related articles for article (PubMed ID: 31122894)
21. Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies.
Ortega HG; Yancey SW; Mayer B; Gunsoy NB; Keene ON; Bleecker ER; Brightling CE; Pavord ID
Lancet Respir Med; 2016 Jul; 4(7):549-556. PubMed ID: 27177493
[TBL] [Abstract][Full Text] [Related]
22. Bone turnover biomarkers in COPD patients randomized to either a regular or shortened course of corticosteroids: a substudy of the randomized controlled CORTICO-COP trial.
Sivapalan P; Jørgensen NR; Mathioudakis AG; Eklöf J; Lapperre T; Ulrik CS; Andreassen HF; Armbruster K; Sivapalan P; Janner J; Godtfredsen N; Weinreich UM; Nielsen TL; Seersholm N; Wilcke T; Schuetz P; Klausen TW; Marså K; Vestbo J; Jensen JU
Respir Res; 2020 Oct; 21(1):263. PubMed ID: 33046053
[TBL] [Abstract][Full Text] [Related]
23. Effect of lung deflation with indacaterol plus glycopyrronium on ventricular filling in patients with hyperinflation and COPD (CLAIM): a double-blind, randomised, crossover, placebo-controlled, single-centre trial.
Hohlfeld JM; Vogel-Claussen J; Biller H; Berliner D; Berschneider K; Tillmann HC; Hiltl S; Bauersachs J; Welte T
Lancet Respir Med; 2018 May; 6(5):368-378. PubMed ID: 29477448
[TBL] [Abstract][Full Text] [Related]
24. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial.
Leuppi JD; Schuetz P; Bingisser R; Bodmer M; Briel M; Drescher T; Duerring U; Henzen C; Leibbrandt Y; Maier S; Miedinger D; Müller B; Scherr A; Schindler C; Stoeckli R; Viatte S; von Garnier C; Tamm M; Rutishauser J
JAMA; 2013 Jun; 309(21):2223-31. PubMed ID: 23695200
[TBL] [Abstract][Full Text] [Related]
25. Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis.
Pavord ID; Lettis S; Anzueto A; Barnes N
Lancet Respir Med; 2016 Sep; 4(9):731-741. PubMed ID: 27460163
[TBL] [Abstract][Full Text] [Related]
26. Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials.
Bafadhel M; Peterson S; De Blas MA; Calverley PM; Rennard SI; Richter K; Fagerås M
Lancet Respir Med; 2018 Feb; 6(2):117-126. PubMed ID: 29331313
[TBL] [Abstract][Full Text] [Related]
27. Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study.
Decramer ML; Chapman KR; Dahl R; Frith P; Devouassoux G; Fritscher C; Cameron R; Shoaib M; Lawrence D; Young D; McBryan D;
Lancet Respir Med; 2013 Sep; 1(7):524-33. PubMed ID: 24461613
[TBL] [Abstract][Full Text] [Related]
28. Oral or IV prednisolone in the treatment of COPD exacerbations: a randomized, controlled, double-blind study.
de Jong YP; Uil SM; Grotjohan HP; Postma DS; Kerstjens HA; van den Berg JW
Chest; 2007 Dec; 132(6):1741-7. PubMed ID: 17646228
[TBL] [Abstract][Full Text] [Related]
29. A randomized, controlled multicentric study of inhaled budesonide and intravenous methylprednisolone in the treatment on acute exacerbation of chronic obstructive pulmonary disease.
Ding Z; Li X; Lu Y; Rong G; Yang R; Zhang R; Wang G; Wei X; Ye Y; Qian Z; Liu H; Zhu D; Zhou R; Zhu K; Ni R; Xia K; Luo N; Pei C
Respir Med; 2016 Dec; 121():39-47. PubMed ID: 27888990
[TBL] [Abstract][Full Text] [Related]
30. Relationship of Blood Eosinophil Count to Exacerbations in Chronic Obstructive Pulmonary Disease.
Zeiger RS; Tran TN; Butler RK; Schatz M; Li Q; Khatry DB; Martin U; Kawatkar AA; Chen W
J Allergy Clin Immunol Pract; 2018; 6(3):944-954.e5. PubMed ID: 29153881
[TBL] [Abstract][Full Text] [Related]
31. Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD).
Oshagbemi OA; Franssen FME; van Kraaij S; Braeken DCW; Wouters EFM; Maitland-van der Zee AH; Driessen JHM; de Vries F
COPD; 2019 Apr; 16(2):152-159. PubMed ID: 31117850
[TBL] [Abstract][Full Text] [Related]
32. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.
Walters JA; Gibson PG; Wood-Baker R; Hannay M; Walters EH
Cochrane Database Syst Rev; 2009 Jan; (1):CD001288. PubMed ID: 19160195
[TBL] [Abstract][Full Text] [Related]
33. COPD patients prescribed inhaled corticosteroid in primary care: time for re-assessment based on exacerbation rate and blood eosinophils?
Savran O; Godtfredsen N; Sørensen T; Jensen C; Ulrik CS
Respir Res; 2021 Feb; 22(1):54. PubMed ID: 33579297
[TBL] [Abstract][Full Text] [Related]
34. Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial.
Yousuf AJ; Mohammed S; Carr L; Yavari Ramsheh M; Micieli C; Mistry V; Haldar K; Wright A; Novotny P; Parker S; Glover S; Finch J; Quann N; Brookes CL; Hobson R; Ibrahim W; Russell RJ; John C; Grimbaldeston MA; Choy DF; Cheung D; Steiner M; Greening NJ; Brightling CE
Lancet Respir Med; 2022 May; 10(5):469-477. PubMed ID: 35339234
[TBL] [Abstract][Full Text] [Related]
35. Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial.
Vestbo J; Papi A; Corradi M; Blazhko V; Montagna I; Francisco C; Cohuet G; Vezzoli S; Scuri M; Singh D
Lancet; 2017 May; 389(10082):1919-1929. PubMed ID: 28385353
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts.
Cheng SL; Lin CH
Int J Chron Obstruct Pulmon Dis; 2016; 11():2341-2348. PubMed ID: 27703344
[TBL] [Abstract][Full Text] [Related]
37. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial.
Brightling CE; Monteiro W; Ward R; Parker D; Morgan MD; Wardlaw AJ; Pavord ID
Lancet; 2000 Oct; 356(9240):1480-5. PubMed ID: 11081531
[TBL] [Abstract][Full Text] [Related]
38. Comparison of two systemic steroid regimens for the treatment of COPD exacerbations.
Ceviker Y; Sayiner A
Pulm Pharmacol Ther; 2014 Apr; 27(2):179-83. PubMed ID: 23518215
[TBL] [Abstract][Full Text] [Related]
39. Corticosteroid Resistance in Smokers-A Substudy Analysis of the CORTICO-COP Randomised Controlled Trial.
Sivapalan P; Bikov A; Suppli Ulrik C; Lapperre TS; Mathioudakis AG; Højberg Lassen MC; Grundtvig Skaarup K; Biering-Sørensen T; Vestbo J; Jensen JS
J Clin Med; 2021 Jun; 10(12):. PubMed ID: 34205765
[TBL] [Abstract][Full Text] [Related]
40. Oral prednisolone in preschool children with virus-associated wheeze: a prospective, randomised, double-blind, placebo-controlled trial.
Foster SJ; Cooper MN; Oosterhof S; Borland ML
Lancet Respir Med; 2018 Feb; 6(2):97-106. PubMed ID: 29373235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
